ADAPTIN BIO, INC.

Adaptin Bio (APTN) has recorded zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting operational stability in the near term. However, low signal in our recent window does not mean low risk; the full Report expands to 12 months of filing history and adds dilution risk scoring, financing trajectory analysis, and AI-flagged anomalies that may not yet surface in standard filings. The full $49 Report adds comprehensive dilution metrics, 8-K context across a full year, and early-warning AI risk signals tied to biotech funding cycles and capital structure changes.